Period Ending | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 |
---|
Total Revenue
|
1,294,000
|
1,614,000
|
1,675,000
| Cost of Revenue | 889,000 | 1,157,000 | 1,124,000 | |
Gross Profit
|
405,000
|
457,000
|
551,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 106,000 | 129,000 | 127,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
299,000
|
328,000
|
424,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (2,000) | 11,000 |
-
|
|
Earnings Before Interest And Taxes | 352,000 | 354,000 | 424,000 |
|
Interest Expense | 147,000 | 148,000 | 147,000 |
|
Income Before Tax | 205,000 | 206,000 | 277,000 |
|
Income Tax Expense | (31,000) | (27,000) | (3,000) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 236,000 | 233,000 | 280,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
| 2,000 |
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
236,000
|
233,000
|
282,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
$236,000
|
$233,000
|
$282,000
|
|